Obituary in the Lancet for Willy Burgdorfer
Jan 11, 2015 — Letter to Allison Snyder who wrote the obituary in the Lancet for Willy Burgdorfer.
From: "Carl Tuttle" <firstname.lastname@example.org>
Cc: "richard horton" <email@example.com>, "abi cantor" <firstname.lastname@example.org>, "john mcconnell" <email@example.com>, "Robert Becker" <Robert.Becker@wolterskluwer.com>, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, email@example.com, firstname.lastname@example.org, "marcia balisciano" <email@example.com>, firstname.lastname@example.org, "dick blumenthal" <email@example.com>, "Kemp Hannon" <firstname.lastname@example.org>, email@example.com, firstname.lastname@example.org, "heather goldstone" <email@example.com>, firstname.lastname@example.org
Sent: Friday, January 9, 2015 9:47:32 AM
Subject: The Lancet: OBITUARY , Willy Burgdorfer
The Lancet: OBITUARY
“…he died from complications of Parkinson's disease on Nov 17, 2014”
Thank you for writing the obituary for Willy Burgdorfer. I have included a recent study below that has identified morphological forms of the bacteria Willy Burgdorfer discovered. It has long been suspected that these forms are responsible for the antibiotic resistance hundreds of thousands (If not millions) of Lyme patients have been complaining about for thirty years.
Do you think Alan Steere and Gary Wormser knew enough about this bacterium as they rushed to produce a vaccine as a cure all for this disease?
The Principle Investigators of the two previous Lyme vaccines: Allen C. Steere for SmithKlineBeecham's LymeRix and Gary Wormser for Connaught's vaccine (which never made it to market) have conceptualized a disease that would enable vaccine development. The one-size-fits-all Lyme treatment guideline (lead author: Gary Wormser) matches the conceptualized disease. A preventive vaccine for Lyme disease would not satisfy the FDA if a chronic persistent infection and seronegative disease exist.
We have been dealing with an antibiotic resistant superbug purposely concealed to promote vaccine development and it has become blatantly obvious that the CDC will go to great lengths to insure that Lyme disease remains within its narrow definition in order to fit the vaccine model. http://home.comcast.net/~runagain/Barbara%20Johnson%20discrediting%20Lyme%20research.doc
A chronic relapsing disease does not fit the vaccine model and post-treatment Lyme disease syndrome is simply a fabricated medical condition disguising treatment failure.
If you are finding this difficult to digest I suggest you review the petition calling for a congressional investigation into the deliberate mishandling of Lyme disease as there are 25,500 signatures and 350 pages of heart wrenching comments from disabled Lyme patients across the globe.
PERSISTENT LYME INFECTION: 273 Peer-Reviewed Studies
CONGENITAL TRANSMISSION OF LYME: 28 Peer-Reviewed Studies
SERONEGATIVITY IN LYME DISEASE: 103 Peer-Reviewed Studies
Here is the latest paper identifying the morphological forms of Borrelia burgdorferi:
Morphological and biochemical features of Borrelia burgdorferi pleomorphic forms.
Meriläinen L, Herranen A, Schwarzbach A, Gilbert L.
Microbiology. pii: mic.0.000027. Online before print, 2015 Jan 6.
Spirochete bacteria Borrelia burgdorferi sensu lato is the causative agent of Lyme disease, the most common tick-borne infection in the Northern hemisphere. There is a long-standing debate regarding the role of pleomorphic forms in Lyme disease pathogenesis, while very little is known about the characteristics of these morphological variants.
Here, we present a comprehensive analysis of B. burgdorferi pleomorphic formation in different culturing conditions at physiological temperature. Interestingly, human serum induced the bacteria to change its morphology to round bodies. In addition, biofilm-like colonies in suspension were found to be part of B. burgdorferi's normal in vitro growth.
Further studies provided evidence that spherical round bodies had an intact and flexible cell envelope demonstrating that they are not cell wall deficient, or degenerative as previously implied. However, the round bodies displayed lower metabolic activity compared to spirochetes.
Furthermore, our results indicated that the different pleomorphic variants were distinguishable by having unique biochemical signatures. Consequently, pleomorphic B. burgdorferi should be taken into consideration as being clinically relevant and influence the development of novel diagnostics and treatment protocols.
Hudson, NH 03051
Website: New Hampshire Lyme Misdiagnosis
Petition: Calling for a Congressional investigation of the CDC, IDSA and ALDF
Latest Update: Faulty FDA approved antibody tests
Letter to the Editor, The Lancet Infectious Diseases Published May 2012
Please continue to forward this petition to educate others. Thank you, Carl Tuttle